Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02498151

Ligand	Ligand name	Chain	PDB	Tanimoto
MNG	MENOGARIL	A,B	202D	0.72
REN	(S)-reticuline	A	3FWA	0.72
REN	(S)-reticuline	A	3D2D	0.72
E20	1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE	A	1EVE	0.74
AB8	(1S,3R,8AS)-8-(2-{(4S,6S)-3-(4-HYDROXY-3-METHOXYBENZYL)-4-[2-(METHYLAMINO)-2-OXOETHYL]-2-OXO-1,3-OXAZINAN-6-YL}ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL (2R)-2-METHYLBUTANOATE	A,B	1XDG	0.74
NGP	NOGALAMYCIN (PROTONATED FORM)	A	1L0R	0.71
C01	(2S)-(4-ISOPROPYLPHENYL)[(2-METHYL-3-OXO-5,7-DIPROPYL-2,3-DIHYDRO-1,2-BENZISOXAZOL-6-YL)OXY]ACETATE	A	1ZEO	0.71
MOI	(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL	H,L	1Q0Y	0.73
NGU	U-58872, HYDROXY DERIVATIVE OF NOGALAMYCIN	A,B	1D22	0.72
GNT	(-)-GALANTHAMINE	A	1DX6	0.7
GNT	(-)-GALANTHAMINE	A	1QTI	0.7
GNT	(-)-GALANTHAMINE	A,B,C,D,E	2PH9	0.7
GNT	(-)-GALANTHAMINE	A,B	1W76	0.7
GNT	(-)-GALANTHAMINE	A	1W6R	0.7
CX6	2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE	A,B,C,D,E,F	2AL4	0.71
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.71
VNL	4-HYDROXY-3-METHOXYBENZOATE	A,B,C,D	2AHC	0.7
VNL	4-HYDROXY-3-METHOXYBENZOATE	A	1XLR	0.7
NLX	(5A,17R)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-6-OXO-17-(2-PROPENYL)-MORPHINANIUM	A,B,C,D,E,F,G,H,I,J,K,L	1MX9	0.77
ERT	METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE	A,B	1TW2	0.72
ERT	METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE	A,B	1TW3	0.72
OBE	3-(3-HYDROXY-BENZOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID	H	1RIV	0.75
HMT	(3beta)-O~3~-[(2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine	0,1,2,3,9,A,B,C,F,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	3G6E	0.75
VXX	VANILLATE	A,B	1WB6	0.71
SYR	SYRINGATE	A,B	1WB5	0.7
BCG	3-(BENZOYLOXY)-8-METHYL-8-AZABICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID	H	1QYG	0.7
FLQ	N-[6-(ACETYLAMINO)HEXYL]-3',6'-DIHYDROXY-3-OXO-3H-SPIRO[2-BENZOFURAN-1,9'-XANTHENE]-6-CARBOXAMIDE	C	2FDC	0.71
NGM	NOGALAMYCIN	A,B,C,D	258D	0.72
NGM	NOGALAMYCIN	A	282D	0.72
NGM	NOGALAMYCIN	A,B	224D	0.72
NGM	NOGALAMYCIN	A,B	245D	0.72
NGM	NOGALAMYCIN	A,B	1QCH	0.72
NGM	NOGALAMYCIN	A	1D17	0.72
NGM	NOGALAMYCIN	A,B	1D21	0.72
NGM	NOGALAMYCIN	A,B	182D	0.72
ADF	4-{[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHOXY}-3-TERT-BUTYLBENZOIC ACID	A	2G5P	0.7
DEO		A,B	1ROS	0.71
AP1	{3-[3-(3,4-DIMETHOXY-PHENYL)-1-(1-{1-[2-(3,4,5-TRIMETHOXY-PHENYL)-BUTYRYL]-PIPERIDIN-2YL}-VINYLOXY)-PROPYL]-PHENOXY}-ACETIC ACID	A,B	1BL4	0.71
GL8	GALANTHAMINE DERIVATIVE	A	1W4L	0.7